Subject(s)
Coronavirus Infections/epidemiology , Coronavirus , Disease Outbreaks/prevention & control , Pandemics , Pneumonia, Viral/epidemiology , Public Health Surveillance/methods , Betacoronavirus , COVID-19 , COVID-19 Testing , Clinical Laboratory Techniques , Contact Tracing , Coronavirus Infections/diagnosis , Coronavirus Infections/drug therapy , Coronavirus Infections/prevention & control , Coronavirus Infections/therapy , Epidemiology , Humans , Pandemics/prevention & control , Pneumonia, Viral/diagnosis , Pneumonia, Viral/prevention & control , Pneumonia, Viral/therapy , Quarantine , SARS-CoV-2 , COVID-19 Drug TreatmentABSTRACT
High throughput screening is a powerful tool to identify the potential candidate molecules involved during disease progression. However, analysis of complicated data is one of the most challenging steps on the way to obtaining useful results from this approach. Previously, we showed that a specific miRNA, miR-196a, could ameliorate the pathological phenotypes of Huntington's disease (HD) in different models, and performed high throughput screening by using the striatum of transgenic mice. In this study, we further tried to identify the potential regulatory mechanisms using different bioinformatic tools, including Database for Annotation, Visualization and Integrated Discovery (DAVID), Molecular Signatures Database (MSigDB), TargetScan and MetaCore. The results showed that miR-196a dominantly altered "ABC transporters", "RIG-I-like receptor signaling pathway", immune system", "adaptive immune system","tissue remodeling and wound repair" and "cytoskeleton remodeling". In addition, miR-196a also changed the expression of several well-defined pathways of HD, such as apoptosis and cell adhesion. Since these analyses showed the regulatory pathways are highly related to the modification of the cytoskeleton, we further confirmed that miR-196a could enhance the neurite outgrowth in neuroblastoma cells, suggesting miR-196a might provide beneficial functions through the alteration of cytoskeleton structures. Since impairment of the cytoskeleton has been reported in several neuronal diseases, this study will provide not only the potential working mechanisms of miR-196a but also insights for therapeutic strategies for use with different neuronal diseases.
Subject(s)
Computational Biology/methods , Corpus Striatum/metabolism , Gene Expression Regulation , Huntington Disease/genetics , MicroRNAs/genetics , Neuroblastoma/genetics , Animals , Biomarkers/metabolism , Corpus Striatum/cytology , Disease Models, Animal , Gene Expression Profiling , Huntington Disease/metabolism , Huntington Disease/pathology , Mice , Mice, Transgenic , Neurites/metabolism , Neuroblastoma/pathology , PhenotypeABSTRACT
Huntington disease (HD) is a dominantly inherited neurodegenerative disorder characterized by dysregulation of various genes. Recently, microRNAs (miRNAs) have been reported to be involved in this dysregulation, suggesting that manipulation of appropriate miRNA regulation may have a therapeutic benefit. Here, we report the beneficial effects of miR-196a (miR196a) on HD in cell, transgenic mouse models, and human induced pluripotent stem cells derived from one individual with HD (HD-iPSCs). In the in vitro results, a reduction of mutant HTT and pathological aggregates, accompanying the overexpression of miR-196a, was observed in HD models of human embryonic kidney cells and mouse neuroblastoma cells. In the in vivo model, HD transgenic mice overexpressing miR-196a revealed the suppression of mutant HTT in the brain and also showed improvements in neuropathological progression, such as decreases of nuclear, intranuclear, and neuropil aggregates and late-stage behavioral phenotypes. Most importantly, miR-196a also decreased HTT expression and pathological aggregates when HD-iPSCs were differentiated into the neuronal stage. Mechanisms of miR-196a in HD might be through the alteration of ubiquitin-proteasome systems, gliosis, cAMP response element-binding protein pathway, and several neuronal regulatory pathways in vivo. Taken together, these results show that manipulating miR-196a provides beneficial effects in HD, suggesting the potential therapeutical role of miR-196a in HD.
Subject(s)
Huntington Disease/genetics , MicroRNAs/genetics , Neurons/metabolism , Pluripotent Stem Cells/metabolism , Serotonin Plasma Membrane Transport Proteins/genetics , Animals , Brain/metabolism , Brain/pathology , Cell Differentiation , Cell Line, Tumor , Disease Models, Animal , Embryo, Mammalian , Gene Expression Regulation , Humans , Huntington Disease/metabolism , Huntington Disease/pathology , Kidney/metabolism , Kidney/pathology , Mice , Mice, Transgenic , MicroRNAs/metabolism , Neurons/cytology , Phenotype , Pluripotent Stem Cells/cytology , Serotonin Plasma Membrane Transport Proteins/metabolism , TransfectionABSTRACT
OBJECTIVE: To determine whether the human corpus luteum exhibits CDC25 protein expression and its expression pattern, and identify the interaction with DAZL (deleted in azoospermia-like) in human luteal cells. DESIGN: Experimental study. SETTING: Medical research laboratory in a university hospital. PATIENT(S): Twelve human corpus luteum (CL), four in the early stage, four in the midstage, and four in the late stage of the luteal phase, respectively, and 10 granulosa-lutein cells from IVF patients. INTERVENTION(S): Immunohistochemical stain and Western blot were used to characterize the expression of CDC25 protein, and protein immunoprecipitation was used to identify the interaction of CDC25 with DAZL in human luteal cells. MAIN OUTCOME MEASURE(S): CDC25 protein expression pattern in different stages of luteal phase and interaction with DAZL. RESULT(S): In this study, we show evidence that CDC25 protein is express in granulosa-lutein cells from different stages of CL, and identified only the CDC25A interaction with DAZL in luteal cells. CONCLUSION(S): The CL is the final form of a developing follicle and is the major endocrine component of the ovary in maintaining early successful pregnancy. Expression of CDC25 protein throughout different stages of the ovarian cycles implies important functional roles in the regulation of female reproduction.
Subject(s)
Corpus Luteum/metabolism , Luteal Phase/physiology , RNA-Binding Proteins/metabolism , cdc25 Phosphatases/metabolism , Blotting, Western , Corpus Luteum/cytology , Female , Fertilization in Vitro , Humans , Immunohistochemistry , Ovarian Follicle/cytology , Ovarian Follicle/metabolism , Protein Binding/physiologyABSTRACT
The in vivo and in vitro effects of Cordyceps sinensis (CS) and its extracted fractions on the secretion of testosterone in mice were studied. CS, F2 (water soluble protein), and F3 (poorly water soluble polysaccharide and protein) significantly stimulated in vitro testosterone production in purified mouse Leydig cells. However, F1 (water soluble polysaccharide) had no effect (p>0.05). F2 and F3 stimulated in vitro testosterone production in dose- and time-dependent relationships with maximal responses at 3 mg/ml for 3 h (p<0.05). An in vivo study illustrated that testosterone levels in plasma were significantly increased by CS, F2, and F3, respectively (p<0.05). Because CS, F2, and F3 stimulated both in vitro and in vivo testosterone secretions in mice, it is possible that CS might contribute to an alternative medicine for the treatment of some reproductive problems caused by insufficient testosterone levels in human males.
Subject(s)
Cordyceps/metabolism , Drugs, Chinese Herbal/pharmacology , Leydig Cells/drug effects , Medicine, Chinese Traditional , Testosterone/metabolism , Animals , Cells, Cultured , Chemical Fractionation , Cordyceps/chemistry , Dose-Response Relationship, Drug , Leydig Cells/metabolism , Male , Mice , Mice, Inbred C57BLABSTRACT
We demonstrate the mechanism by which Cordyceps sinensis (CS) mycelium regulates Leydig cell steroidogenesis. Mouse Leydig cells were treated with forskolin, H89, phorbol 12-myristate 13-acetate, staurosporine, or steroidogenic enzyme precursors with or without 3 mg/ml CS; then testosterone production was determined. H89, but not phorbol 12-myristate 13-acetate or staurosporine, decreased CS-treated Leydig cell steroidogenesis. CS inhibited Leydig cell steroidogenesis by suppressing the activity of P450scc enzyme, but not 3beta-hydroxysteroid dehydrogenase, 17alpha-hydroxylase, 20alpha-hydroxylase, or 17beta-hydroxysteroid dehydrogenase enzymes. Thus, CS activated the cAMP-protein kinase A signal pathway, but not protein kinase C, and attenuated P45scc enzyme activity to reduce human chorionic gonadotropin-stimulated steroidogenesis in purified mouse Leydig cells.
Subject(s)
Cordyceps/physiology , Leydig Cells/metabolism , Sulfonamides , Testosterone/biosynthesis , Androstenedione/metabolism , Animals , Cells, Cultured , Colforsin/pharmacology , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Hydroxycholesterols/pharmacology , Isoquinolines/pharmacology , Leydig Cells/drug effects , Leydig Cells/enzymology , Male , Mice , Mice, Inbred C57BL , Mycelium/physiology , Progestins/metabolism , Protein Kinase C/antagonists & inhibitors , Staurosporine/pharmacology , Tetradecanoylphorbol Acetate/pharmacologyABSTRACT
OBJECTIVE: To identify the DAZL transcript and protein location in human spermatozoa. DESIGN: In vitro experiment. SETTING: University-based reproductive genetics laboratory. PATIENT(S): A fertile volunteer. INTERVENTION(S): Reverse transcription-polymerase chain reaction (RT-PCR), Western blot, and immunostaining for DAZL. MAIN OUTCOME MEASURE(S): Expression of DAZL in human spermatozoa. RESULT(S): The DAZL-specific primers yield a 128 bp product in ejaculate. A protein of approximately 33.5 kDa was detected by Western blot analysis. Immunofluorescence staining showed strong homogeneous staining in the midpiece of spermatozoa and weak staining in the principal piece. A speckled-type distribution was found in the head region. CONCLUSION(S): The DAZL transcript and protein are present in human spermatozoa. The roles of DAZL protein in sperm motility and in the sperm-oocyte interaction await further investigation.